Innovating Novel Combination Therapies & Maximising Preclinical & Clinical Development to Improve Glioblastoma Targeting & Increase Investment Opportunities to Ultimately Bring Efficacious Therapies to Patients in Need
The glioblastoma drug development space has been energized by Merck's acquisition of Modifi Bio last December. This landmark deal has sparked renewed hope in a field long challenged by limited investment and clinical breakthroughs.
Looking ahead to 2026, it's crucial to sustain this momentum. The 7th Glioblastoma Drug Development Summit is your essential platform for accelerating new treatments and continuing this vital progress.
Join us for a definitive, 3-day summit designed to accelerate progress. With groundbreaking content and six deep-dive workshops, you'll connect with over 90 leading experts from every corner of the field - from biotech to investment. This is your opportunity to uncover the latest advancements, learn how to overcome funding challenges, and explore the transformative role of AI in glioblastoma.
Together, we’ll unlock actionable insights, forge powerful partnerships, and secure the future of your pipeline and move towards the delivery of transformative therapies for one of the most devastating and underserved cancers.
The diverse content that covered everything from funding GBM trials to new technologies/approaches to early clinical solutions. The round tables were a good way to promote discussion.
Chief Business Officer, Global Coalition for Adaptive Research
I was extremely pleased with the way the entire summit was organized. Everything from the line up of the speakers to the networking opportunities was very well planned and executed.
VP, Research & Development, Diakonos Oncology
The summit covered diverse important topics in GBM field, ranging from more basic to clinical and investment. Great opportunities for discussion on key open topics to understand perspective from leaders in their area of focus.
CEO, Medicenna Therapeutics
Explore the Full Event Guide
- 90+ industry attendees
- 25+ World Class Speaker
- 6 deep-dive workshops, covering end-to-end drug development
- 8+ Hours on Networking
- The world’s only industry-led forum focussed on Glioblastoma drug development
Attending Companies Include
Explore Related Events
Explore the Agenda
Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.